Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
Neurocrine Biosciences and Sosei Heptares Announce Collaboration to Develop Novel Muscarinic Receptor Agonists for Schizophrenia and Other Neuropsychiatric Disorders
Neurocrine Biosciences, Inc. (Nasdaq: NBIX) and Sosei Group Corporation (“Sosei Heptares“; TSE: 4565) announce the signing […]
Nestle Health Science Partners with Healint to Initiate a Fully Virtual Study on Ketogenic Treatment for Migraines
Nestlé Health Science (NHSc) has initiated a study looking into the effectiveness of a ketogenic […]
Caris Precision Oncology Alliance Announces the Addition of Columbia University Irving Medical Center to Its Collaborative Network of Precision Medicine Experts
Caris Life Sciences® (Caris), the leading molecular science and technology company actively developing and delivering innovative […]
Helix and Cue Health Collaborate to Provide Individuals with Access to their COVID-19 Variant Sequencing Information
Helix, a leading genomics company that provides nationwide viral surveillance of respiratory disease, and Cue […]
Sanofi Invests $180 Million Equity in Owkin ’s Artificial Intelligence and Federated Learning to Advance Oncology Pipeline
Sanofi announced today an equity investment of $180 million and a new strategic collaboration with […]
NHS Deal On Spinal Muscular Atrophy (SMA) First Home Treatment
A life-changing drug that can improve mobility in children and adults with a rare genetic […]
Exact Sciences and Jefferson Health Commence Collaboration on Multi-Cancer Earlier Detection
Exact Sciences Corp. (NASDAQ: EXAS) today announced an agreement with Jefferson Health (Jefferson) to conduct research on […]
Terumo Blood and Cell Technologies and Immunicom Establish Agreement to Launch Breakthrough Cancer Immunotherapy Treatment in Europe
Terumo Blood and Cell Technologies, a medical technology company specializing in a portfolio of products, […]
Cellenion and Thermo Fisher Scientific Announce Partnership for Single Cell Mass Spectrometry-Based Proteomics Analysis
Cellenion, a BICO company, announced today a co-marketing agreement with Thermo Fisher Scientific to advance single cell proteomics analyses. […]
Entos and BioMarin Enter into Agreement for Product Candidates Incorporating Entos' Fusogenix Drug Delivery Platform
Entos Pharmaceuticals, Inc. (Entos), a clinical-stage biotechnology company developing genetic medicines with its Fusogenix proteolipid […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more